🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in individuals injecting products of uncertain source.

Several professionals said the popularity for retatrutide could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and customer regulations, risking fines, prosecution or prison.

Service Response and Material Elimination

Based on the social media company, the service has taken down violative content and banned related hashtags and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.

Digital Trading Activities

Research also found groups with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with photos of slimming results, positive reviews and detailed guides for mixing or administering at home.

Within moments of joining one community, a vendor shared contact information, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Product Details and Costs

Within these groups, posts show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service said it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her team has previously encountered individuals injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to potentially serious medical dangers”.